Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Szwiega S, Pencharz PB, Rafii M, Lebarron M, Chang J, Ball RO, Kong D, Xu L, Elango R, Courtney-Martin G
Jensen SS, Petterson SA, Halle B, Aaberg-Jessen C, Kristensen BW (2017) Effects of the lysosomal destabilizing drug siramesine on glioblastoma in vitro and in vivo
Here is what the science actually shows and where the gaps still are
Patients were deemed eligible for participation if they were at least 18 years of age, diagnosed with type 2 diabetes and insufficient glycemic control, measured by HbA1c levels, as well as treatment with diet and exercise or a stable dose of metformin
US$ 20.86
US$ 26.11
US$ 20.96
US$ 25.27
US$ 26.47
